Advertisement
Screener

Cartesian Therapeutics, Inc. (RNAC) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

Cartesian Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

Cartesian Therapeutics, Inc. (RNAC) reported Increase (Decrease) in Prepaid Expense and Other Assets of $89.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$157.00K.
  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $246.00K, a 95.78% decline year-over-year.
  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$264.00K.
  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $438.00K, a 78.99% decline year-over-year.
  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $5.30M.
  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.75M, a 238.10% decline from fiscal 2023.
  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.26M.
  • Cartesian Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.47M, a 270.30% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30-$157.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$89.00K
10-Q · filed 2026-08-06
-$175.00K
derived: sum of 3 quarters · filed 2026-08-06
$263.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$246.00K
10-Q · filed 2026-04-30
-$18.00K
derived: sum of 2 quarters · filed 2026-04-30
$420.00K
derived: sum of 3 quarters · filed 2026-04-30
-$286.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$264.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$174.00K
derived: sum of 2 quarters · filed 2026-03-09
-$532.00K
derived: sum of 3 quarters · filed 2026-08-06
$5.30M
10-K · filed 2026-03-09
2025-09-30$438.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$268.00K
derived: sum of 2 quarters · filed 2026-08-06
$5.56M
10-Q · filed 2025-11-06
$4.58M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$706.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$5.12M
10-Q · filed 2026-08-06
$4.14M
derived: sum of 3 quarters · filed 2026-08-06
$6.22M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$5.83M
10-Q · filed 2026-04-30
$4.85M
derived: sum of 2 quarters · filed 2026-04-30
$6.93M
derived: sum of 3 quarters · filed 2026-04-30
$5.74M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$984.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$1.10M
derived: sum of 2 quarters · filed 2026-03-09
-$95.00K
derived: sum of 3 quarters · filed 2026-03-09
-$1.75M
10-K · filed 2026-03-09
2024-09-30$2.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$889.00K
derived: sum of 2 quarters · filed 2025-11-06
-$763.00K
10-Q · filed 2025-11-06
$472.00K
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$1.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$2.85M
10-Q · filed 2025-08-07
-$1.61M
derived: sum of 3 quarters · filed 2025-08-07
-$768.00K
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$1.65M
10-Q · filed 2025-05-08
-$417.00K
derived: sum of 2 quarters · filed 2025-05-08
$428.00K
derived: sum of 3 quarters · filed 2025-05-08
-$407.00K
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
$2.08M
derived: sum of 2 quarters · filed 2025-03-13
$1.25M
derived: sum of 3 quarters · filed 2025-03-13
$1.26M
10-K · filed 2025-03-13
2023-09-30$845.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$10.00K
derived: sum of 2 quarters · filed 2024-11-07
$30.00K
10-Q · filed 2024-11-07
-$2.75M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$835.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$815.00K
10-Q · filed 2024-08-08
-$3.59M
derived: sum of 3 quarters · filed 2024-08-08
-$3.66M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$20.00K
10-Q · filed 2024-05-08
-$2.75M
derived: sum of 2 quarters · filed 2024-05-08
-$2.83M
derived: sum of 3 quarters · filed 2024-05-08
-$1.60M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31-$2.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$2.85M
derived: sum of 2 quarters · filed 2024-03-07
-$1.62M
derived: sum of 3 quarters · filed 2024-03-07
-$2.47M
10-K · filed 2024-03-07
2022-09-30-$70.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$1.16M
derived: sum of 2 quarters · filed 2023-11-13
$304.00K
10-Q · filed 2023-11-13
$1.25M
derived: sum of 4 quarters · filed 2024-03-07
2022-06-30$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17
$374.00K
10-Q · filed 2023-08-17
$1.31M
derived: sum of 3 quarters · filed 2024-03-07
-$986.00K
derived: sum of 4 quarters · filed 2024-03-07
2022-03-31-$853.00K
10-Q · filed 2023-05-04
$88.00K
derived: sum of 2 quarters · filed 2024-03-07
-$2.21M
derived: sum of 3 quarters · filed 2024-03-07
-$914.00K
derived: sum of 4 quarters · filed 2024-03-07
2021-12-31$941.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$1.36M
derived: sum of 2 quarters · filed 2024-03-07
-$61.00K
derived: sum of 3 quarters · filed 2024-03-07
$1.45M
10-K · filed 2024-03-07
2021-09-30-$2.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$1.00M
derived: sum of 2 quarters · filed 2022-11-03
$510.00K
10-Q · filed 2022-11-03
-$1.73M
derived: sum of 4 quarters · filed 2023-03-02
2021-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$2.81M
10-Q · filed 2022-08-08
$573.00K
derived: sum of 3 quarters · filed 2023-03-02
$7.68M
derived: sum of 4 quarters · filed 2023-03-02
2021-03-31$1.51M
10-Q · filed 2022-05-05
-$726.00K
derived: sum of 2 quarters · filed 2023-03-02
$6.38M
derived: sum of 3 quarters · filed 2023-03-02
$5.87M
derived: sum of 4 quarters · filed 2023-03-02
2020-12-31-$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$4.87M
derived: sum of 2 quarters · filed 2023-03-02
$4.36M
derived: sum of 3 quarters · filed 2023-03-02
$4.42M
10-K · filed 2023-03-02
2020-09-30$7.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$6.59M
derived: sum of 2 quarters · filed 2021-11-09
$6.66M
10-Q · filed 2021-11-09
$6.55M
derived: sum of 4 quarters · filed 2022-03-10
2020-06-30-$512.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$451.00K
10-Q · filed 2021-08-12
-$560.00K
derived: sum of 3 quarters · filed 2022-03-10
-$1.44M
derived: sum of 4 quarters · filed 2022-03-10
2020-03-31$61.00K
10-Q · filed 2021-05-13
-$48.00K
derived: sum of 2 quarters · filed 2022-03-10
-$929.00K
derived: sum of 3 quarters · filed 2022-03-10
-$9.28M
derived: sum of 4 quarters · filed 2022-03-10
2019-12-31-$109.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$990.00K
derived: sum of 2 quarters · filed 2022-03-10
-$9.34M
derived: sum of 3 quarters · filed 2022-03-10
-$3.18M
10-K · filed 2022-03-10
2019-09-30-$881.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$9.23M
derived: sum of 2 quarters · filed 2020-11-05
-$3.07M
10-Q · filed 2020-11-05
-$4.08M
10-Q · filed 2019-11-08
-$3.25M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30-$8.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.19M
10-Q · filed 2020-08-06
-$2.91M
10-Q · filed 2019-08-08
-$2.37M
derived: sum of 3 quarters · filed 2021-03-12
$335.00K
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$6.16M
10-Q · filed 2020-05-07
$5.71M
10-Q · filed 2019-05-09
$5.97M
derived: sum of 2 quarters · filed 2021-03-12
$8.68M
derived: sum of 3 quarters · filed 2021-03-12
$9.21M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31-$185.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$2.52M
derived: sum of 2 quarters · filed 2021-03-12
$3.05M
derived: sum of 3 quarters · filed 2021-03-12
$2.63M
10-K · filed 2021-03-12
2018-09-30$2.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$3.23M
derived: sum of 2 quarters · filed 2019-11-08
$2.82M
10-Q · filed 2019-11-08
$1.91M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30$524.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$107.00K
10-Q · filed 2019-08-08
-$801.00K
derived: sum of 3 quarters · filed 2020-03-12
$238.00K
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31-$417.00K
10-Q · filed 2019-05-09
-$1.32M
derived: sum of 2 quarters · filed 2020-03-12
-$286.00K
derived: sum of 3 quarters · filed 2020-03-12
-$1.96M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31-$908.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$131.00K
derived: sum of 2 quarters · filed 2020-03-12
-$1.54M
derived: sum of 3 quarters · filed 2020-03-12
-$1.23M
10-K · filed 2020-03-12
-$525.00K
10-K · filed 2018-03-15
2017-09-30$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$633.00K
derived: sum of 2 quarters · filed 2018-11-08
-$317.00K
10-Q · filed 2018-11-08
$386.00K
10-Q · filed 2017-11-07
-$1.15M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30-$1.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
-$1.36M
10-Q · filed 2018-08-08
-$656.00K
10-Q · filed 2017-08-11
-$2.19M
derived: sum of 3 quarters · filed 2019-03-15
-$1.06M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$316.00K
10-Q · filed 2018-05-09
-$521.00K
derived: sum of 2 quarters · filed 2019-03-15
$610.00K
derived: sum of 3 quarters · filed 2019-03-15
$1.11M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31-$837.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$294.00K
derived: sum of 2 quarters · filed 2019-03-15
$796.00K
derived: sum of 3 quarters · filed 2019-03-15
$831.00K
10-K · filed 2019-03-15
$860.00K
10-K · filed 2017-03-28
2016-09-30$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$1.63M
derived: sum of 2 quarters · filed 2017-11-07
$1.67M
10-Q · filed 2017-11-07
$2.07M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$502.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11
$537.00K
10-Q · filed 2017-08-11
$940.00K
derived: sum of 3 quarters · filed 2018-03-15
$1.32M
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31$35.00K
10-Q · filed 2017-05-11
$438.00K
derived: sum of 2 quarters · filed 2018-03-15
$816.00K
derived: sum of 3 quarters · filed 2018-03-15
2015-12-31$403.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$781.00K
derived: sum of 2 quarters · filed 2018-03-15
$1.01M
10-K · filed 2018-03-15
2015-09-30$378.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$608.00K
10-Q · filed 2016-11-10
2015-06-30$230.00K
10-Q · filed 2016-08-09
2014-12-31$404.00K
10-K · filed 2017-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23